US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ceribell

14.71

+0.14000.96%

Volume:62.97K

Turnover:911.34K

Market Cap:527.62M

PE:-4.35

High:14.90

Open:14.51

Low:14.08

Close:14.57

Loading ...

Overview Company News Filings

CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm

MT Newswires Live

BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

THOMSON REUTERS

FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older

Top Midday Gainers

MT Newswires Live

Ceribell jumps after saying no impact from incremental tariffs until Q4

CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4

MT Newswires Live

With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest

Simply Wall St.

CeriBell Initiated at Buy by Ladenburg Thalmann

Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target

MT Newswires Live

Ceribell initiated with a Buy at Ladenburg

Ceribell, Inc. Announces Executive Compensation Adjustments

Top Premarket Gainers

MT Newswires Live

CeriBell Is Maintained at Buy by Canaccord Genuity

Ceribell, Inc.: Strong Financial Performance and Strategic Investments Justify Buy Rating

CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ...

Ceribell, Inc. Reports Strong 2024 Financial Growth

Ceribell, Inc.: Strong Financial Performance and Growth Potential Drive Buy Rating

CeriBell Inc reports results for the quarter ended December 31 - Earnings Summary

CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":14.71,"timestamp":1744817343005,"preClose":14.57,"halted":0,"volume":62970,"delay":0,"floatShares":21912409,"shares":35868339,"eps":-3.385363,"marketStatus":"Trading","change":0.14,"latestTime":"04-16 11:29:13 EDT","open":14.51,"high":14.9,"low":14.076,"amount":911343.08535,"amplitude":0.056555,"askPrice":14.78,"askSize":100,"bidPrice":14.5,"bidSize":366,"shortable":3,"etf":0,"ttmEps":-3.385363,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1744833600000},"marketStatusCode":2,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":14.57,"preHourTrading":{"tag":"盘前","latestPrice":13.87,"preClose":14.57,"latestTime":"09:16 EDT","volume":23,"amount":325.399998,"timestamp":1744809403937},"postHourTrading":{"tag":"盘后","latestPrice":14.57,"preClose":14.57,"latestTime":"18:02 EDT","volume":2089,"amount":30437.57,"timestamp":1744754576331},"volumeRatio":0.217267,"impliedVol":1.0607,"impliedVolPercentile":0.9167},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":21912409,"roa":"-17.46%","roe":"-35.75%","lyrEps":-3.385363,"volumeRatio":0.217267,"shares":35868339,"dividePrice":0,"high":14.9,"amplitude":0.056555,"preClose":14.57,"low":14.076,"week52Low":10.01,"pbRate":"2.76","psRate":"8.06","week52High":32.7489,"institutionHeld":0,"latestPrice":14.71,"committee":0.570815,"eps":-3.385363,"divideRate":0,"volume":62970,"delay":0,"ttmEps":-3.385363,"open":14.51,"prevYearClose":25.88,"prevWeekClose":15,"prevMonthClose":19.21,"prevQuarterClose":19.21,"fiveDayClose":19.23,"twentyDayClose":20.635,"sixtyDayClose":22.94},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527412547","title":"CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm","url":"https://stock-news.laohu8.com/highlight/detail?id=2527412547","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527412547?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:29","pubTimestamp":1744723756,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) said Tuesday its Clarity algorithm has received 510(k) clearance from the US Food and Drug Administration for the detection of electrographic seizures in patients aged at least one.The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2527414230","title":"BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2527414230","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527414230?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:26","pubTimestamp":1744723591,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Clears Ceribell’S Clarity Algorithm For Pediatric PatientsApril 15 (Reuters) - CeriBell Inc CBLL.O:FDA CLEARS CERIBELL’S CLARITY ALGORITHM FOR PEDIATRIC PATIENTS, MAKING CERIBELL THE FIRST A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2527490440","title":"FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2527490440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527490440?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:01","pubTimestamp":1744718495,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2527011412","title":"FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2527011412","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527011412?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:00","pubTimestamp":1744718400,"startTime":"0","endTime":"0","summary":"Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies. FDA clearance of Ceribell’s Clarity algorithm will enable rapid, bedside detection, diagnosis, and treatment of non-convulsive seizures in children experiencing neurological emergencies.\"We believe this clearance will have a profound impact on the lives of critically ill children, who are particularly vulnerable to preventable brain injury,\" said Jane Chao, Ph.D., co-founder and CEO of Ceribell. \"It is well understood that seizures can lead to poor clinical outcomes when not treated in a timely manner. Yet, until now, clinicians have never had access to point-of-care EEG with a seizure detection algorithm tailored specifically for pediatric patients as young as 1 year old. This breakthrough, which we expect to be commercially available soon, marks another important step toward our mission of making rapid EEG ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-clears-ceribell-clarity-algorithm-120000953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2526461466","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526461466","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526461466?lang=en_us&edition=fundamental","pubTime":"2025-04-12 02:25","pubTimestamp":1744395915,"startTime":"0","endTime":"0","summary":"MSP Recovery (MSPR) shares surged 90% after the company said late Thursday that it agreed to a term sheet for several restructuring deals with Hazel Partners, Virage Capital Management, and their affi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["THTX","BK4196","CBLL","MSPR","BK4082","BK4139"],"gpt_icon":0},{"id":"2526619916","title":"Ceribell jumps after saying no impact from incremental tariffs until Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619916","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526619916?lang=en_us&edition=fundamental","pubTime":"2025-04-12 01:40","pubTimestamp":1744393214,"startTime":"0","endTime":"0","summary":"Shares of Ceribell (CBLL) are soaring in Friday trading after the company said in an 8K filing that it expects no material impact to its financial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-jumps-after-saying-no-impact-from-incremental-tariffs-until-q4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-jumps-after-saying-no-impact-from-incremental-tariffs-until-q4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2526616105","title":"CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4","url":"https://stock-news.laohu8.com/highlight/detail?id=2526616105","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526616105?lang=en_us&edition=fundamental","pubTime":"2025-04-12 01:37","pubTimestamp":1744393043,"startTime":"0","endTime":"0","summary":"CeriBell  shares jumped over 34% in recent trading Friday after the company disclosed it was insulated from Trump tariffs until at least Q4.The company sources manufacturing and assembly of its headband product from two vendors in China, with final quality inspection and packaging taking place in California, it said.CeriBell said it had enough supply of finished headband products to last through at least Q3.\"Because the company accounts for product inventory cost of goods sold on a first-in, first-out basis, the company does not expect any material impact to its financial results from incremental tariffs until at least [Q4] 2025,\" CeriBell said in a regulatory filing.Once the current inventory of finished goods is sold, CeriBell expects the impact to its total gross margins by 8 to 10 percentage points, based on the current tariff of 145% on all imports from China.The company's total gross margin recorded for the year ended Dec. 31, 2024, was 87%, it said.Price: 14.98, Change: +3.83, P","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2526472599","title":"With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2526472599","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526472599?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:08","pubTimestamp":1744294102,"startTime":"0","endTime":"0","summary":"Institutions' substantial holdings in CeriBell implies that they have significant influence over the company's share price. 51% of the business is held by the top 6 shareholders. Using data from  analyst forecasts alongside ownership research, one can better assess the future performance of a company. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.If you want to know who really controls CeriBell, Inc. , then you'll have to look at the makeup of its share registry. With 49% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.Let's take a closer look to see what t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/49-stake-ceribell-inc-nasdaq-140822891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU2095319765.USD","LU2210150020.SGD",".IXIC","BK4082","MNQmain","QID","NDAQ","BK4585","QLD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","TQQQ","BK4112","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","USAW.SI","SQQQ","PSQ","NQmain","IE00BGHQF748.EUR","CBLL","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2524209836","title":"CeriBell Initiated at Buy by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2524209836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524209836?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:24","pubTimestamp":1743769440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 04, 2025 08:24 ET (12:24 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2524208703","title":"Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208703","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208703?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:20","pubTimestamp":1743765619,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) has an average rating of buy and mean price target of $33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBLL"],"gpt_icon":0},{"id":"2524720887","title":"Ceribell initiated with a Buy at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2524720887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524720887?lang=en_us&edition=fundamental","pubTime":"2025-04-04 18:40","pubTimestamp":1743763223,"startTime":"0","endTime":"0","summary":"Ladenburg initiated coverage of Ceribell (CBLL) with a Buy rating and $32 price target The company has a first-mover advantage in scaling rapid ele...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-initiated-with-a-buy-at-ladenburg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2519312403","title":"Ceribell, Inc. Announces Executive Compensation Adjustments","url":"https://stock-news.laohu8.com/highlight/detail?id=2519312403","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519312403?lang=en_us&edition=fundamental","pubTime":"2025-03-15 03:17","pubTimestamp":1741979858,"startTime":"0","endTime":"0","summary":"An update from Ceribell, Inc. ( ($CBLL) ) is now available. On March 10, 2025, Ceribell, Inc. announced adjustments to the compensation packages of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-announces-executive-compensation-adjustments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-announces-executive-compensation-adjustments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2519283806","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2519283806","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519283806?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:42","pubTimestamp":1741866155,"startTime":"0","endTime":"0","summary":"AvidXchange Holdings (AVDX) shares soared 27% pre-bell Thursday following a muted session.Reservoir Media (RSVR) shares surged 23% after closing flat on Wednesday.Proficient Auto Logistics (PAL) share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","PAL","BK4227","BK4120","PAL.AU","BK4106","BK4232","RSVR","BK4108","PESI","BK4082","AVDX","CBLL","BK7048"],"gpt_icon":0},{"id":"2514863800","title":"CeriBell Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514863800?lang=en_us&edition=fundamental","pubTime":"2025-02-27 01:14","pubTimestamp":1740590040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2025 12:14 ET (17:14 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2514183759","title":"Ceribell, Inc.: Strong Financial Performance and Strategic Investments Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514183759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514183759?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:57","pubTimestamp":1740574624,"startTime":"0","endTime":"0","summary":"Ceribell, Inc. (CBLL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Travis Steed from Ban...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-strong-financial-performance-and-strategic-investments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-strong-financial-performance-and-strategic-investments-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2514004412","title":"CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514004412","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514004412?lang=en_us&edition=fundamental","pubTime":"2025-02-26 15:15","pubTimestamp":1740554131,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.CeriBell Inc  reported a 41% increase in Q4 2024 revenue, reaching $18.5 million, and a 45% increase for the full year, totaling $65.4 million.The company achieved strong gross margins of 88% in Q4 and 87% for the full year 2024, reflecting efficient manufacturing processes.CeriBell Inc  expanded its active accounts to 529 by the end of 2024, with a strategic focus on targeting 5,500 remaining prospective accounts.The company is investing in R&D to expand its product indications, including pediatric and neonate clarity algorithms, and has received FDA breakthrough device designation for delirium detection.CeriBell Inc  successfully completed an upsized IPO, raising approximately $188 million, which will be used to accelerate R&D and commercial expansion.Q: Gross margin came in better than expected. What are your thoughts on gross margin and OpEx spend for 2025?A: We have exposure to Chin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ceribell-inc-cbll-q4-2024-071531054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CBLL"],"gpt_icon":0},{"id":"2514307283","title":"Ceribell, Inc. Reports Strong 2024 Financial Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2514307283","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514307283?lang=en_us&edition=fundamental","pubTime":"2025-02-26 12:26","pubTimestamp":1740543983,"startTime":"0","endTime":"0","summary":"Ceribell, Inc. ( ($CBLL) ) has released its Q4 earnings. Here is a breakdown of the information Ceribell, Inc. presented to its investors. Ceribell...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-2024-financial-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceribell-inc-reports-strong-2024-financial-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2514073959","title":"Ceribell, Inc.: Strong Financial Performance and Growth Potential Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514073959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514073959?lang=en_us&edition=fundamental","pubTime":"2025-02-26 10:35","pubTimestamp":1740537312,"startTime":"0","endTime":"0","summary":"Analyst Josh Jennings of TD Cowen maintained a Buy rating on Ceribell, Inc. (CBLL – Research Report), retaining the price target of $36.00. Josh Je...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ceribell-inc-strong-financial-performance-and-growth-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ceribell-inc-strong-financial-performance-and-growth-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2514382047","title":"CeriBell Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2514382047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514382047?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:01","pubTimestamp":1740520864,"startTime":"0","endTime":"0","summary":"CeriBell Inc reports results for the quarter ended December 31 - Earnings SummaryCeriBell Inc CBLL.OQ reported a quarterly adjusted loss of 40 cents per share for the quarter ended December 31.  The m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG2T8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2514447880","title":"CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514447880","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514447880?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:32","pubTimestamp":1740519163,"startTime":"0","endTime":"0","summary":"CeriBell (NASDAQ:CBLL) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.32) by 25 percent. This is a 73.86 percent increase over losses of $(1.53) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43958077/ceribell-q4-gaap-eps-0-40-misses-0-32-estimate-sales-18-53m-beat-17-55m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2025-04-15","current":-13.192952,"percent":0.992063,"low":-31.439367,"twenty":-28.401057,"median":-23.038577,"eighty":-19.002107,"high":-9.885848,"avg":-23.501843,"sd":4.56581,"marketCap":533720884},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-15","current":-13.192952,"twenty":-28.401057,"median":-23.038577,"eighty":-19.002107,"marketCap":533720884}],"updateTime":1744808932705}}}